<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD), <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) are characterized by ongoing mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> in which dysfunction of the host immunologic response against dietary factors and commensal bacteria is involved </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory process leads to disruption of the epithelial barrier, and the formation of epithelial ulceration </plain></SENT>
<SENT sid="2" pm="."><plain>This permits easy access for the <z:chebi fb="2" ids="8069">luminal</z:chebi> microbiota and dietary antigens to cells resident in the lamina propria, and stimulates further pathological immune cell responses </plain></SENT>
<SENT sid="3" pm="."><plain>Cytokines are essential mediators of the interactions between activated immune cells and non-immune cells, including epithelial and mesenchymal cells </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical efficacy of targeting TNF-alpha clearly indicates that cytokines are the therapeutic targets in IBD patients </plain></SENT>
<SENT sid="5" pm="."><plain>In this manuscript, we focus on the biological activities of recently-reported cytokines [Interleukin (IL)-17 cytokine family, IL-31 and IL-32], which might play a role through interaction with TNF-alpha in the pathophysiology of IBD </plain></SENT>
</text></document>